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as well as an increased labeling index and increased level of plasmino-
gen activator. Un involved psoriatic epidermis after grafting shows 
increases in the labeling index and plasminogen activator level similar 
to those seen in grafts from lesional ski n. No detectable inflammatory 
infiltrate is reported in grafted epidermis. Thus, involved and unin-
volved psoriatic sk in can display markers (e.g., acanthosis, increased 
labeling index, and increased plasminogen activator level) independent 
of the host and such host factors as stratum corneum Ig binding and 
Munro microabscess formation. 
The presence of lgG, lgM, lgA, and plasma fibronectin in paraker-
atotic stratum corneum of lesions of psorias is, verruca vulgaris, actinic 
keratosis, and lichen simplex chronicus, but not in orthokeratotic 
stratum corneum of other lesions [1] is compatible with macromo-
lecular leakage from lesional microvasculature and high affinity binding 
at sites of parakeratosis. 
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